57.54
price up icon2.90%   1.62
after-market Handel nachbörslich: 57.54
loading
Schlusskurs vom Vortag:
$55.92
Offen:
$56.2
24-Stunden-Volumen:
658.22K
Relative Volume:
0.74
Marktkapitalisierung:
$6.03B
Einnahmen:
$628.56M
Nettoeinkommen (Verlust:
$141.82M
KGV:
71.04
EPS:
0.81
Netto-Cashflow:
$142.60M
1W Leistung:
+11.02%
1M Leistung:
+17.62%
6M Leistung:
+101.05%
1J Leistung:
+127.07%
1-Tages-Spanne:
Value
$56.14
$57.70
1-Wochen-Bereich:
Value
$51.69
$57.70
52-Wochen-Spanne:
Value
$20.84
$61.66

Corcept Therapeutics Inc Stock (CORT) Company Profile

Name
Firmenname
Corcept Therapeutics Inc
Name
Telefon
650.688.8803
Name
Adresse
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
Mitarbeiter
352
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
CORT's Discussions on Twitter

Vergleichen Sie CORT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
CORT 57.54 6.03B 628.56M 141.82M 142.60M 0.81
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-06 Hochstufung Truist Hold → Buy
2023-04-11 Eingeleitet SVB Securities Market Perform
2023-04-04 Eingeleitet Piper Sandler Overweight
2023-02-15 Herabstufung Jefferies Buy → Hold
2022-08-01 Herabstufung Truist Buy → Hold
2022-07-27 Hochstufung Jefferies Hold → Buy
2022-06-27 Fortgesetzt Canaccord Genuity Buy
2022-02-02 Eingeleitet Canaccord Genuity Buy
2022-01-28 Eingeleitet Truist Buy
2020-08-05 Herabstufung Jefferies Buy → Hold
2019-09-24 Eingeleitet Jefferies Buy
2019-09-06 Eingeleitet H.C. Wainwright Buy
2019-02-04 Herabstufung B. Riley FBR Buy → Neutral
2018-08-10 Bestätigt Stifel Hold
2018-05-31 Herabstufung Stifel Buy → Hold
2018-03-09 Eingeleitet B. Riley FBR, Inc. Buy
2017-08-31 Eingeleitet Stifel Buy
2017-02-02 Eingeleitet Ladenburg Thalmann Buy
2015-04-21 Eingeleitet FBR Capital Outperform
2014-01-13 Herabstufung Stifel Buy → Hold
2013-08-09 Herabstufung Janney Buy → Neutral
2013-08-09 Herabstufung Ladenburg Thalmann Buy → Neutral
2012-02-21 Bestätigt JMP Securities Mkt Outperform
2010-01-06 Hochstufung Ladenburg Thalmann Neutral → Buy
2008-07-17 Eingeleitet Rodman & Renshaw Mkt Outperform
2007-06-21 Hochstufung Punk, Ziegel & Co Mkt Perform → Accumulate
Alle ansehen

Corcept Therapeutics Inc Aktie (CORT) Neueste Nachrichten

pulisher
Nov 22, 2024

Corcept Shares Rise More Than 60% In Three Months: Here's Why - Barchart

Nov 22, 2024
pulisher
Nov 22, 2024

Corcept Shares Rise More Than 60% in Three Months: Here's Why - Yahoo Finance

Nov 22, 2024
pulisher
Nov 22, 2024

Q4 EPS Forecast for Corcept Therapeutics Lifted by Analyst - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

3 Reasons Growth Investors Will Love Corcept (CORT) - Yahoo Finance

Nov 21, 2024
pulisher
Nov 21, 2024

Empowered Funds LLC Buys Shares of 38,541 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 21, 2024
pulisher
Nov 20, 2024

Corcept Therapeutics Stock Surges 61% in 2024: A Must Buy? - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Wall Street Analysts Think Corcept (CORT) Could Surge 37.91%: Read This Before Placing a Bet - Yahoo Finance

Nov 20, 2024
pulisher
Nov 20, 2024

Connor Clark & Lunn Investment Management Ltd. Raises Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 20, 2024
pulisher
Nov 17, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Sold by Cornercap Investment Counsel Inc. - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Royce & Associates LP Has $16.81 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Teva Defends Mifepristone Antitrust Case Against Corcept - Law360

Nov 15, 2024
pulisher
Nov 15, 2024

Intellectus Partners LLC Purchases Shares of 54,859 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Average Target Price from Analysts - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Corcept Therapeutics director Daniel Swisher sells $131,736 in stock By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Principal Financial Group Inc. Sells 20,770 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Corcept Therapeutics director Daniel Swisher sells $131,736 in stock - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Corcept (CORT) Upgraded to Strong Buy: Here's Why - MSN

Nov 13, 2024
pulisher
Nov 13, 2024

Cushing's Syndrome Market to Show a Rise During the Study Period | - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

Cushing's Syndrome Market Will Drive an Exponential CAGR - openPR

Nov 13, 2024
pulisher
Nov 12, 2024

Corcept Therapeutics Incorporated (NASDAQ:CORT) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

24,800 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Versor Investments LP - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Wealth Enhancement Advisory Services LLC Takes $238,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Lisanti Capital Growth LLC Increases Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar And Theravance - Barchart

Nov 11, 2024
pulisher
Nov 11, 2024

Zacks Industry Outlook Madrigal, Corcept, Catalyst Larimar and Theravance - Yahoo Finance

Nov 11, 2024
pulisher
Nov 11, 2024

CWA Asset Management Group LLC Acquires Shares of 20,800 Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Robeco Institutional Asset Management B.V. Trims Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 11, 2024
pulisher
Nov 09, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 8.9%Time to Buy? - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

US Bancorp DE Purchases 12,177 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

M&G Plc Buys New Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

Corcept Therapeutics Incorporated (CORT) Soars to 52-Week High, Time to Cash Out? - MSN

Nov 07, 2024
pulisher
Nov 06, 2024

New York State Teachers Retirement System Sells 17,222 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 06, 2024
pulisher
Nov 05, 2024

Corcept Therapeutics' chief development officer sells $489,700 in stock - Investing.com

Nov 05, 2024
pulisher
Nov 05, 2024

Corcept Therapeutics' chief development officer sells $489,700 in stock By Investing.com - Investing.com UK

Nov 05, 2024
pulisher
Nov 05, 2024

Here is Why Growth Investors Should Buy Corcept (CORT) Now - Yahoo Finance

Nov 05, 2024
pulisher
Nov 05, 2024

Corcept Stock At New High; Will The Upcoming Regulatory And Clinical Trial Catalysts Take It Higher? - RTTNews

Nov 05, 2024
pulisher
Nov 05, 2024

Roman Butler Fullerton & Co. Has $261,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Creative Planning Acquires 841 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World

Nov 05, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 - Investing.com India

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics (NASDAQ:CORT) Sets New 1-Year HighWhat's Next? - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Corcept Therapeutics stock soars to all-time high of $50.23 By Investing.com - Investing.com Australia

Nov 04, 2024
pulisher
Nov 04, 2024

Wall Street Analysts Believe Corcept (CORT) Could Rally 56.66%: Here's is How to Trade - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Recent Price Trend in Corcept (CORT) is Your Friend, Here's Why - Yahoo Canada Finance

Nov 04, 2024
pulisher
Nov 04, 2024

What is HC Wainwright’s Forecast for CORT FY2024 Earnings? - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

HC Wainwright Has Bullish Forecast for CORT FY2024 Earnings - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

What is HC Wainwright’s Estimate for CORT FY2026 Earnings? - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View - MSN

Nov 02, 2024
pulisher
Nov 02, 2024

Corcept Therapeutics (CORT) Stock Declines Amid Market Activity - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Earnings Estimates Moving Higher for Corcept (CORT): Time to Buy? - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 3.2%Here's What Happened - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

FY2026 Earnings Estimate for CORT Issued By HC Wainwright - MarketBeat

Nov 01, 2024

Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Kapitalisierung:     |  Volumen (24h):